Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 20 Key Players companies in Voglibose
by Most Patent Filings in the world in 2022

The Voglibose top 20 is Discovery PatSnap’ annual ranking of the top 20 Most Patent Filings Voglibose Key Players in the world. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Voglibose (INN and USAN, trade name Voglib, marketed by Mascot Health Series) is an alpha-glucosidase inhibitor used for lowering post-prandial blood glucose levels in people with diabetes mellitus. Voglibose delays the absorption of glucose thereby reducing the risk of macrovascular complications. Voglibose is a research product of Takeda Pharmaceutical Company, Japan's largest pharmaceutical company. Voglibose was first launched in 1994, under the trade name BASEN, to improve postprandial hyperglycemia in diabetes mellitus.
#
Company Name
Region
Tech Topics
Total
1
Haryana, India
Health care,Drug,Active ingredient,
...[+2]
Patent: 7
2
Patent: 7
3
Drug development,Drug discovery,Gastrointestinal agent,
...[+2]
Patent: 6
4
Maharashtra, India
Patent: 6
5
Switzerland
Patent: 6
6
Medicine,Health care,Clinical trial,
...[+2]
Patent: 4
7
Drug,Generic drug,Over-the-counter,
...[+2]
Patent: 4
8
Patent: 4
9
Patent: 4
10
Patent: 3
11
Patent: 3
12
Patent: 3
13
Patent: 3
14
Patent: 2
15
Patent: 2
16
Nordrhein-Westfalen, Germany
Health care,Biology,Chemical engineering,
...[+2]
Patent: 1
17
Patent: 1
18
Patent: 1
19
Yarn,Aramid,Fiber,
...[+2]
Patent: 1
20
Patent: 1
Page generation time: Aug 10 2025